mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
المؤلفون الرئيسيون: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Nature Portfolio
2022-08-01
|
سلاسل: | npj Vaccines |
الوصول للمادة أونلاين: | https://doi.org/10.1038/s41541-022-00511-y |
مواد مشابهة
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
حسب: Susanne Rauch, وآخرون
منشور في: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
حسب: Nicole Roth, وآخرون
منشور في: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
حسب: Charlie Fricke, وآخرون
منشور في: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
حسب: Nicole Roth, وآخرون
منشور في: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
حسب: Björn Corleis, وآخرون
منشور في: (2023-02-01)